Concentrix slides after $1.05 billion impairment charge drives Q3 loss
Concentrix shares fell 11.5% to $22.02 premarket after a $1.05 billion non-cash goodwill impairment led to a Q3 loss of $16.24 per share. Q3 revenue was $2.45 billion vs $2.48 billion estimates; adj. EPS was $2.92 vs $2.71 estimates.
05 billion non-cash goodwill impairment charge. 71 forecast. 72. Of 6 brokerages covering the stock, 3 rate it buy or higher and 3 rate it hold; the median target price is $30.
16% year to date.